Broad Institute, Cambridge, MA, USA.
J Clin Invest. 2012 Jul;122(7):2439-43. doi: 10.1172/JCI63597. Epub 2012 Jun 18.
Diamond-Blackfan anemia (DBA) is a hypoplastic anemia characterized by impaired production of red blood cells, with approximately half of all cases attributed to ribosomal protein gene mutations. We performed exome sequencing on two siblings who had no known pathogenic mutations for DBA and identified a mutation in the gene encoding the hematopoietic transcription factor GATA1. This mutation, which occurred at a splice site of the GATA1 gene, impaired production of the full-length form of the protein. We further identified an additional patient carrying a distinct mutation at the same splice site of the GATA1 gene. These findings provide insight into the pathogenesis of DBA, showing that the reduction in erythropoiesis associated with the disease can arise from causes other than defects in ribosomal protein genes. These results also illustrate the multifactorial role of GATA1 in human hematopoiesis.
Diamond-Blackfan 贫血症(DBA)是一种以红血细胞生成受损为特征的低增生性贫血症,约一半的病例归因于核糖体蛋白基因突变。我们对两个没有已知 DBA 致病突变的兄弟姐妹进行了外显子组测序,发现了一个编码造血转录因子 GATA1 的基因突变。该突变发生在 GATA1 基因的剪接位点,影响全长蛋白的产生。我们进一步鉴定了另一名患者携带相同 GATA1 基因剪接位点的另一个突变。这些发现为 DBA 的发病机制提供了深入了解,表明与该疾病相关的红细胞生成减少可能并非源自核糖体蛋白基因缺陷。这些结果还说明了 GATA1 在人类造血中的多因素作用。